| A Study of Patritumab Deruxtecan (HER3-DXd) in Combination With Trastuzumab Deruxtecan (T-DXd) in Participants With HR-Positive, HER2-Low or HER2-Ultralow Unresectable or Metastatic Breast Cancer (NCT07701941) | Daiichi Sankyo | 2026-08-03 |
| A Study of More Frequent Dosing of VCN-01 Combined With Standard Chemotherapy in Patients With Newly Diagnosed Metastatic Pancreatic Cancer (NCT07701486) | Theriva Biologics SL | 2026-08-03 |
| CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma (NCT07257419) | St. Jude Children's Research Hospital | 2026-08-03 |
| A Study of ART105 in Healthy Adult Participants (NCT07748026) | Arnatar Therapeutics, Inc. | 2026-08-03 |
| A Research Study to See How NNC0487-0111 Affects the Body's Energy Use After a Weight Loss in Adults Living With Obesity, Compared to a Low-calorie Diet or Placebo (NCT07757087) | Novo Nordisk A/S | 2026-08-03 |
| DSP-0390 in Combination With Atezolizumab for Small Cell Lung Cancer (NCT07545954) | Washington University School of Medicine | 2026-08-03 |
| Phase I/II Clinical Trial of UX-DA003 Injection for the Treatment of Patients With Parkinson's Disease (NCT07733349) | Shanghai UniXell Biotechnology Co., Ltd | 2026-08-03 |
| A Phase I Clinical Trial to Evaluate Pharmacokinetics of HS-10504 (NCT07770217) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2026-08-02 |
| A Study of the Metabolic Reconstruction Oral Biologics (Gut-X-001) Medication in People With Alzheimer's Disease (ESCAPE-AD) (NCT07591727) | Beijing Tiantan Hospital | 2026-08-01 |
| A Study of MRG007 Combination Therapy for Advanced Colorectal Cancer (NCT07737600) | Lepu Biopharma Co., Ltd. | 2026-08-01 |
| A Phase 1 Trial of GEN1119 in Participants With Solid Tumors (NCT07695831) | Genmab | 2026-08-01 |
| E.N.D.E.A.V.O.R.: An Exemestane Needed Dose Efficacy and Verification as an Ovulation Induction Regimen Study (NCT07706374) | University of North Carolina, Chapel Hill | 2026-08-01 |
| A Phase Ib Study of VK-2019 in Patients With Relapsed or Refractory EBV+ Diffuse Large B-cell Lymphomas (DLBCL) (NCT06789159) | Pierluigi Porcu | 2026-08-01 |
| Multi-Cohort Study of Zeprumetostat Combinations for Relapsed/Refractory PTCL (NCT07724782) | Tianjin Medical University Cancer Institute and Hospital | 2026-08-01 |
| Bridging Study of XKH001 in Healthy Adult Caucasian Participants (NCT07757659) | Zhejiang Kanova Biopharmaceutical Co., LTD | 2026-08-01 |
| ANO31905 in Combination With Chemotherapy for CLDN18.2-Positive Locally Advanced Unresectable or Metastatic Pancreatic Cancer (NCT07444541) | Anova Innovation Limited | 2026-08-01 |
| 64Cu-GRIP B in Patients With Acute Myocarditis (NCT07481136) | Javid Moslehi, MD | 2026-08-01 |
| Tolerability of Ropeginterferon Alfa-2b Add-on to Ongoing Ruxolitinib Therapy in Myelofibrosis (RopeRux in Myelofibrosis) (NCT07521046) | University of Utah | 2026-08-01 |
| Drospirenone-Primed Ovarian Stimulation Versus GnRH Antagonist Protocol in Poor Ovarian Responders Undergoing Freeze-All IVF/ICSI (NCT07736261) | Ahmed Saad | 2026-08-01 |
| Study of Cabozantinib With Selumetinib for Plexiform Neurofibromas (NCT06502171) | Girish Dhall, MD | 2026-08-01 |
| FAPI PET Imaging - An Exploratory Study (NCT07705074) | Martin Huellner | 2026-08-01 |
| A Clinical Study to Evaluate Single-agent Therapy of BR113 for Injection in Patients With Advanced Solid Tumors (NCT07753590) | BioRay Pharmaceutical Co., Ltd. | 2026-08-01 |
| Upadacitinib in Treatment of JAK/STAT Pathway Disorders With Activating Mutations (NCT07670156) | Lisa Satter | 2026-08-01 |
| A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma (NCT07192471) | Kyowa Kirin, Inc. | 2026-08-01 |
| A Study of BL-ARC002 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid Tumors (NCT07763652) | Sichuan Baili Pharmaceutical Co., Ltd. | 2026-08-01 |
| Safety and Efficacy Study of GEB-101 Injection in Subjects With TGFBI-related Corneal Dystrophy (NCT07750678) | GenEditBio Limited | 2026-08-01 |
| A Phase I Clinical Trial to Evaluate the Effect of Itraconazole on the Pharmacokinetics of HS-10504 (NCT07764692) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2026-08-01 |
| A Study to Evaluate the Safety of SHR-7590 in Chinese Healthy Participants and in Patients With Moderate-to-Severe Ulcerative Colitis (NCT07758101) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2026-08-01 |
| Safety and Feasibility of FMT for Immune Recovery After HSCT (NCT07755319) | The First Affiliated Hospital of Soochow University | 2026-08-01 |
| Methamphetamine Isomer Pharmacology in Humans (NCT06746831) | University of Wisconsin, Madison | 2026-08-01 |
| YMN-136 Vaccine for Patients With Advanced Hepatobiliary and Pancreatic Malignancies (NCT07763301) | West China Hospital | 2026-08-01 |
| A Phase I/II Open-label, Single-arm, Multicenter Clinical Study to Evaluate the Safety and Efficacy of FKC289 in Subjects With Relapsed/Refractory Membranous Nephropathy (NCT07765537) | Shenzhen Fosun Kairos Biotechnology Co., Ltd. | 2026-08-01 |
| A Study of SI-B036 in Patients With Locally Advanced or Metastatic Head and Neck Tumors and Other Solid Tumors (NCT07763639) | Sichuan Baili Pharmaceutical Co., Ltd. | 2026-08-01 |
| A Phase 1/2 Study of KK2430 in Participants With Hematologic Neoplasms (NCT07629726) | Kyowa Kirin Co., Ltd. | 2026-08-01 |
| Tislelizumab in Combination With Bevacizumab and Capecitabine in Advanced Solid Tumors With Evaluation in Immunotherapy-Resistant and Central Nervous System Disease (NCT07681297) | National University Hospital, Singapore | 2026-08-01 |
| Personalized Cancer Vaccine (PCV) Strategy in Triple Negative Breast Cancer Patients (NCT07300475) | Washington University School of Medicine | 2026-08-01 |
| A Multicenter, Open-label Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of SHR-6914 Injection in Participants With Prostate Cancer (NCT07735377) | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 2026-08-01 |
| Safety and Efficacy of BMS-986504 in Unresectable Malignant Peripheral Nerve Sheath Tumor (NCT07549022) | Ankit Mangla, MD | 2026-08-01 |
| A Study of APG-3288 in Relapsed/Refractory Blood Cancers (NCT07424833) | Ascentage Pharma Group Inc. | 2026-08-01 |
| H1ssF Flu Vaccine Clinical Trial (NCT07340047) | University of Minnesota | 2026-08-01 |
| HS235 Study in Obese Participants With Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction (HFpEF) (NCT07123779) | 35Pharma Inc | 2026-08-01 |
| Effect of GnRH Agonist in FET (NCT07653282) | Assiut University | 2026-08-01 |
| 129Xe MRI in Pediatric Population With BPD (NCT04035629) | Xemed LLC | 2026-08-01 |
| 211At-MABG in Adults With Advanced Neuroendocrine Cancers (NCT07661420) | University of Pennsylvania | 2026-08-01 |
| DEC003M in Prostate Cancer (NCT07657806) | Hangzhou DAC Biotechnology Co., Ltd. | 2026-08-01 |
| Thermotherapy for Head and Neck Cancer Patients (NCT07690618) | Erasmus Medical Center | 2026-08-01 |
| Long-Term Follow-Up Study for RB001 Gene Therapy Study in Children With SHANK3-related Phelan McDermid Syndrome (PMS) (NCT07690527) | Peking University First Hospital | 2026-08-01 |
| A Study on the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Dose of SHR-7012 in Healthy Adults (NCT07749651) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2026-08-01 |
| XTX501 in Patients With Metastatic Non-Small Cell Lung Cancer and Advanced Solid Tumors (NCT07688577) | Xilio Development, Inc. | 2026-08-01 |
| Neoadjuvant Propranolol Plus SOX and Toripalimab for Locally Advanced Gastric/GEJ Adenocarcinoma (NCT07727993) | Ting Liu | 2026-08-01 |
| A Study to Evaluate Claudin 18.2-Directed ADC LCB02A in Advanced Solid Tumors (NCT07460375) | LigaChem Biosciences, Inc. | 2026-08-01 |
| A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of DNL921 in Healthy Participants and Participants With Alzheimer's Disease (NCT07758595) | Denali Therapeutics Inc. | 2026-08-01 |
| Escalating Cycle 1 Dose of Lu-177-PSMA-617 for the Treatment of Metastatic Castration Resistant Prostate Cancer (NCT07682649) | University of Michigan Rogel Cancer Center | 2026-08-01 |
| Study of QUAIL-100 in Pediatric and Young Adult Participants With High-Risk Hematologic Malignancies Who Have Received a Hematopoietic Stem Cell Transplantation (NCT07573111) | Laguna Biotherapeutics, Inc. | 2026-08-01 |
| Psilocybin Assisted Psychotherapy for Treatment Resistant Depression and Co-occurring Substance Use Disorder (NCT07499583) | Indiana University | 2026-08-01 |
| Intratumoral MMR Vaccine Injection in Borderline Resectable/Unresectable Pancreatic Cancer (NCT07539155) | University of Arkansas | 2026-08-01 |
| A Positron Emission Tomography (PET) Study to Evaluate Dopamine D2 and D3 Receptor Occupancy by SIPI6398 (NCT07626034) | Shanghai Zhongze Therapeutics Co., Ltd. | 2026-08-01 |
| A Study to Assess the Safety, Tolerability and Pharmacokinetics of Viaca (Sildenafil + Cabergoline) Compared With Sildenafil and Cabergoline (NCT07732387) | Yanping Kong | 2026-08-01 |
| Safety, Tolerability, Pharmacokinetics, and Mosquitocidal Activity of Lotilaner in Healthy Participants in Mali. (NCT07758985) | Medicines for Malaria Venture | 2026-08-01 |
| A Study of CHM-029 in Participants With NPM1 Mutated, KMT2A or NUP98 Rearranged AML (NCT07751991) | Charm Therapeutics | 2026-08-01 |
| Bacteriophages for Adults With Cystic Fibrosis and Chronic Achromobacter Lung Infection (NCT07275905) | Ghady Haidar | 2026-08-01 |
| Repeated Injections of Adipose-derived Stem Cells in Rotator Cuff Tears (NCT07592936) | University of Southern Denmark | 2026-08-01 |
| Pharmacokinetics, Safety, and Immunogenicity of Bmab1800 and Keytruda® as Adjuvant Monotherapy in Patients With Melanoma (NCT07581509) | Biocon Biologics UK PLC | 2026-08-01 |
| A Study of LY4226695 in Healthy Participants (NCT07767487) | Eli Lilly and Company | 2026-08-01 |
| Xylitol Use for Decolonization of C. Difficile in Patients With IBD (NCT05852587) | Brigham and Women's Hospital | 2026-08-01 |
| Imaging Study of [89Zr]DFO-YS5 for Cancer Detection (NCT07664397) | Robert Flavell, MD, PhD | 2026-08-01 |
| ML-016 in Advanced Cancer With Lung and/or Liver Involvement (NCT07723482) | BrYet US, Inc. | 2026-08-01 |
| Comparative PK Assessment Study of Casdatifan in Moderate Hepatically Impaired Participants Versus Matched Participants With Normal Hepatic Function (NCT07751250) | Arcus Biosciences, Inc. | 2026-08-01 |
| CAN1012 in Pre-Malignant DCIS and LCIS (NCT07408856) | Providence Health & Services | 2026-08-01 |
| Characterization of Doxycycline Pharmacokinetics and Adherence (NCT07755618) | HIV Prevention Trials Network | 2026-08-01 |
| Sonication-based OCD Neurosurgical Intervention Via Capsulotomy (NCT06131502) | Brigham and Women's Hospital | 2026-08-01 |
| Pharmacokinetics, Safety, and Immunogenicity Comparison of Bmab1700 and Opdivo® as Adjuvant Monotherapy in Participants With Melanoma (NCT07476326) | Biocon Biologics UK PLC | 2026-08-01 |
| Transcranial Ultrasound Stimulation for Tourette Syndrome (NCT07699783) | University of Calgary | 2026-08-01 |
| A Phase 1 Clinical Trial of Adjuvanted Protein-based HCV Vaccine Candidates (HCV Vaccine Trial) (NCT07237282) | University of Alberta | 2026-08-01 |
| Safety and Efficacy of Autologous Adipose-derived Mesenchymal Stem Cells Therapy in Adults With Atrophic Scars (NCT07474467) | CellinCells | 2026-08-01 |
| Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid Tumors (NCT07487168) | H. Lee Moffitt Cancer Center and Research Institute | 2026-08-01 |
| TEPH: Telaglenastat Efficacy in Pulmonary Hypertension (NCT07223528) | Chan, Stephen, MD, PhD | 2026-08-01 |
| A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia (NCT07734493) | Leal Therapeutics, Inc | 2026-08-01 |
| Axatilimab Combined With Decitabine/Venetoclax for the Treatment of TP53-mutated AML (NCT07511062) | Northside Hospital, Inc. | 2026-08-01 |
| Safety and Pharmacokinetics Study of Multiple Ascending Doses of VV261 Tablets (NCT07710326) | Vigonvita Life Sciences | 2026-08-01 |
| Rituximab for Treatment of Checkpoint Inhibitor Induced Immune-related Adverse Events (NCT07694414) | Inge Marie Svane | 2026-08-01 |
| Study on the Effect of Famotidine on Pharmacokinetics of Taletrectinib (NCT07742384) | Nuvation Bio Inc. | 2026-08-01 |
| Investigating the Combination of Bexmarilimab and Nivolumab in Solid Tumours, Melanoma and NSCLC (NCT07718243) | Institute of Cancer Research, United Kingdom | 2026-08-01 |
| VK4-116 Phase I Study With Food-Effect (NCT06808932) | National Institute on Drug Abuse (NIDA) | 2026-08-01 |
| Allogeneic NK Cell Therapy Combined With Standard Maintenance Treatment in Advanced Solid Tumors (NCT07551778) | BOE Technology Group Co., Ltd. | 2026-08-01 |
| A Study of HL40626S Tablets in Healthy Adults (NCT07736586) | HighsLab Therapeutics Inc. | 2026-08-01 |
| Panitumumab-IRDye800 to Detect Pediatric Neoplasms During Neurosurgical Procedures (NCT04085887) | Stanford University | 2026-08-01 |
| Preventive Dendritic Cell Vaccination for Lynch Syndrome (NCT07412197) | Radboud University Medical Center | 2026-08-01 |
| TCR1188-ABC Cells in KRAS-mutated Cancers (NCT07594067) | University of Pennsylvania | 2026-08-01 |
| Phase I Clinical Study Evaluating the Relative Bioavailability of Different Formulations of HRS-5346 in Healthy Participants (NCT07752069) | Shandong Suncadia Medicine Co., Ltd. | 2026-08-01 |
| A Study to Evaluate ATX-898 in Participants With Advanced Solid Tumors (NCT07767474) | Antares Therapeutics, Inc | 2026-08-01 |
| dMD-002 Pilot Study in Patients With Cavernous Nerve Injury Following Radical Prostatectomy (NCT07564102) | Mochida Medical USA, Inc. | 2026-08-01 |
| Second Trimester Abortion With Letrozole and Misoprostol Compared to Misoprostol Alone (NCT07767435) | Sohag University | 2026-08-01 |
| IN10018 in Combination With Dalpiciclib for Progressive Meningiomas (NCT07652762) | Capital Medical University | 2026-08-01 |
| Taste Acceptance and Effectiveness of Hyaluronic Acid and Chlorhexidine Mouthwashes in Children With Gingivitis (NCT07662226) | Cairo University | 2026-08-01 |
| Restoration of Knee Extension After ACL Reconstruction (NCT07685561) | University of Alabama at Birmingham | 2026-08-01 |
| A Trial of HRS-7085 Tablets in Patients With Moderate to Severe Active Ulcerative Colitis (NCT07760831) | Jiangsu HengRui Medicine Co., Ltd. | 2026-08-01 |
| Study Evaluating the Safety and Feasibility of Panitumumab-IRDye800 and [18F]NOTA-ABY-030 for Targeted Dual-Modality Imaging (TDMI) in Head and Neck Squamous Cell Carcinoma (NCT07741643) | Vanderbilt-Ingram Cancer Center | 2026-08-01 |
| A Study of BYN-001 in Healthy Adults and in Adults With Moderate to Severe Atopic Dermatitis (NCT07746817) | Bionyra Pharma | 2026-08-01 |
| A Study of SI-B036 in Patients With Locally Advanced or Metastatic Urological Tumors and Other Solid Tumors (NCT07744243) | Sichuan Baili Pharmaceutical Co., Ltd. | 2026-08-01 |